CSF3 and acute myocardial infarction: This approach was recently tested in a phase III clinical trial using Sitagliptin (Safety and efficacy of SITAgliptin plus Granulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction, SITAGRAMI).